Roslin Technologies
Roslin Technologies is a UK biotechnology company that develops and supplies pluripotent animal stem cell lines (iPSC and ESC) and scale-up media/protocols to cultivated meat producers globally, and applies the same platform to animal health partnerships.
- Company typePrivate
- Founded2016
- HeadquartersEdinburgh, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Roslin Technologies firmographics
Firmographics- Name
- Roslin Technologies
- Legal name
- Roslin Technologies Limited
- Website
- https://roslintech.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Roslin Technologies is a UK biotechnology company that develops and supplies pluripotent animal stem cell lines (iPSC and ESC) and scale-up media/protocols to cultivated meat producers globally, and applies the same platform to animal health partnerships.
- Ownership category
- akta.pro rank
Roslin Technologies industry classification
Industry- Product category
- Cultivated Meat Cell Lines
- NAICS
- Other Animal Production (1129), Animal Slaughtering and Processing (31161)
- SIC
- Meat Packing Plants (2011)
- akta.pro primary industry
- Cell Line Development & Banking (Food/AG Cell Lines) (AFANAKAE)
- akta.pro secondary industry
- Cultivated Meat Producers (Cell-Cultured Meat & Seafood) (AFANAKAC)
Keywords
Where Roslin Technologies is headquartered
LocationHeadquarters
- HQ city
- Edinburgh
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Roslin Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Cell line product sales (B2B): Sale of proprietary animal stem cell lines (Porcine iPSC, Bovine ESC, Ovine iPSC, Ovine ESC) as off-the-shelf catalog products in standard or suspension-adapted vials shipped on dry ice to cultivated meat producers worldwide.
- Scale-up packages and supporting products: Revenue from bundled cell line plus food-safe growth media, differentiation protocols and technical transfer, enabling customers to scale production.
- Custom / tail-ended cell line development and licensing: Joint development of new cell lines with customers and development collaborators; licensing and commercialisation of intellectual property from University of Edinburgh's Royal (Dick) School of Veterinary Studies and the Roslin Institute. New species (e.g., Bovine iPSC, Salmon) being developed.
- Animal health / veterinary cell line development partnerships: Commercial partnerships such as the Likarda canine iPS cell line collaboration, applying the same stem cell platform to animal therapeutics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Enquiry-based pricing for cell line products and scale-up packages; catalog sizes in standard or suspension-adapted vials. |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Roslin Technologies product offering
Product offeringCore offering
Roslin Technologies develops and supplies animal stem cell lines (porcine iPSC, bovine ESC, ovine iPSC, ovine ESC, plus bovine iPSC and salmon lines in development) for cultivated meat producers. Its commercial offering bundles the cell lines with scale-up and differentiation packages, food-safe media, cell banking and characterization services, and regulatory support, sold primarily to other cellular agriculture businesses developing cell-cultivated meat products.
Product overview
Roslin Technologies operates a single-platform cell line business targeting the cultivated meat industry, centred on pluripotent animal stem cell derivation and supply. The portfolio is unified around iPSC and ESC technologies across multiple species: the core, commercially available offerings are Porcine iPSC, Bovine ESC, Ovine iPSC and Ovine ESC, complemented by Bovine iPSC and Salmon cell lines in development. These cell line products are bundled with supporting scale-up and differentiation packages, food-safe cell culture media, cell banking and characterisation services, and tailored customer support including training and data for novel food regulatory dossiers, allowing cultivated meat producers to bring products to market faster with lower cost and risk.
Differentiator
Problem solved
Functional benefit
Products and services
- Porcine iPSC line
Quantifiable outcome
- 61% reduction in cell culture media cost via University of Edinburgh / IBioIC collaboration
- +3 more outcomes
Companies that use Roslin Technologies
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Roslin Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Roslin Technologies partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered major and flagship.
- Aleph FarmsmajorIsraeli cultured meat startup completing the first phase of a cross-platform partnership using Roslin Technologies' growth medium to culture cells. Demonstrates platform flexibility, consistency and potential for cost reduction, supporting broader biomanufacturing ambitions including medical and cosmetics industries.
- MultusmajorGrowth media partner in an industry collaboration highlighted in Protein Production Technology International as accelerating cultivated meat development. Forms part of a plug-and-play collaboration ecosystem with Roslin Technologies and The Cultured Hub.
- The Cultured HubmajorBioprocessing partner in the Multus-Roslin Tech-Cultured Hub collaboration ecosystem featured in Protein Production Technology International as an example of plug-and-play framework fostering innovation and faster cultivated meat commercialisation.
- Industrial Biotechnology Innovation Centre (IBioIC)majorSupported a project with the University of Edinburgh that developed a new approach to cell generation, eliminating batch-to-batch variation, cutting cell culture media cost by 61%, and demonstrating scale-up from 500 mL to 5 L bioreactor (target 2,000 L).
- University of Edinburgh (Roslin Institute)flagshipCo-developed with Roslin Technologies (and IBioIC) a new approach to cell generation that cuts cell culture media cost by 61% and demonstrates bioreactor scale-up. University provides privileged access to expertise and intellectual property.
- LikardamajorExtended commercial partnership on canine iPS cell lines for companion animal regenerative medicine (e.g., diabetes in dogs). Likarda is a leading regenerative medicine company for companion animals.
- University of EdinburghflagshipRoslin Technologies was founded in 2017 as a venture between two investment firms and the University of Edinburgh; the company holds certain rights to commercialise intellectual property from the University's Royal (Dick) School of Veterinary Studies and the Roslin Institute, a global leader in animal science. Prof Catherine Martin is Vice Principal of Corporate Services at the University.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Roslin Technologies competitors and assessment
Company assessmentDirect peers
- Multus: Multus is a UK-based cultivated meat startup that produces growth media and recombinant proteins used by cultivated meat producers. Both Roslin Technologies and Multus supply critical upstream inputs (cells and media respectively) to the same cultivated meat customer base, and they are positioned as complementary partners in the same plug-and-play ecosystem.
- The Cultured Hub: The Cultured Hub is a Singapore-based bioprocess and scale-up services provider for cultivated meat companies, co-located with A*STAR and other Singapore foodtech players. Both firms sit in the cultivated meat B2B enablement layer, providing scale-up capabilities that complement Roslin's cell line supply to the same producer customers.
Emerging players
- Aleph Farms: Aleph Farms is an Israeli cultivated meat company producing cell-cultivated beef steaks. As both a Roslin customer and an emerging player in the same cultivated meat category, it provides both commercial validation and a potential example of vertical integration that could compete with Roslin in the future.
- Mosa Meat: Mosa Meat is a Dutch cultivated beef company and one of the category pioneers (spun out of Maastricht University in 2013). It is comparable to Roslin Technologies as a cultivated meat innovator targeting the same beef end-market, though Mosa Meat is a producer while Roslin supplies upstream cell technology.
- Meatable: Meatable is a Dutch cultivated meat startup developing pork and beef using iPSC technology with proprietary single-step differentiation. It directly parallels Roslin Technologies' iPSC platform approach; Roslin's VP Development Jef Pinxteren previously worked at Meatable on scale-up, underlining the technical overlap.
- Upside Foods: Upside Foods (formerly Memphis Meats) is a US cultivated meat leader producing cell-cultivated chicken, beef and duck. Comparable as a cultivated meat pioneer with proprietary cell line capabilities; represents both a potential customer and a future vertical competitor to Roslin's cell line supply model.
- BlueNalu: BlueNalu is a US cultivated seafood company developing cell-cultivated fish products. Comparable to Roslin's seafood expansion ambitions (Roslin has a salmon cell line in development), and represents both a potential customer and a peer in defining the cultivated meat/cultivated seafood category.
- Eat Just (GOOD Meat): Eat Just's GOOD Meat division is one of the first cultivated meat businesses to receive regulatory approval and reach consumers (Singapore). Comparable to Roslin as a cultivated meat category pioneer and potential customer for animal cell lines, with the additional strategic significance of having navigated novel food regulatory pathways.
Broad incumbents
- Cellular Dynamics International (Fujifilm CDI): Fujifilm Cellular Dynamics International is a leading commercial iPSC provider focused on human cell applications (drug discovery, cell therapy, toxicology). Comparable to Roslin as a pioneer commercial iPSC platform company; Roslin's CSO Deepika Rajesh previously led R&D at CDI, and CDI's expertise and IP base provide an indirect benchmark for animal iPSC commercialisation.
- Bio-Techne: Bio-Techne is a large US life sciences tools company supplying cell culture reagents, media, and stem cell research products globally. Comparable as a supplier of inputs into the stem cell and cell therapy ecosystem in which Roslin operates, with significantly broader portfolio scale but less specialisation in cultivated meat-specific animal iPSC/ESC lines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks5 records
Key highlights7 records
Customer concentration
Roslin Technologies social profiles
Digital presenceRoslin Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roslin Technologies leadership team
Management profileNumber of profiles
Roslin Technologies funding detail
Funding detailFunding overview
Funding rounds9 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roslin Technologies M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roslin Technologies
What does Roslin Technologies do?
Roslin Technologies develops and supplies animal stem cell lines (porcine iPSC, bovine ESC, ovine iPSC, ovine ESC, plus bovine iPSC and salmon lines in development) for cultivated meat producers. Its commercial offering bundles the cell lines with scale-up and differentiation packages, food-safe media, cell banking and characterization services, and regulatory support, sold primarily to other cellular agriculture businesses developing cell-cultivated meat products.
Is Roslin Technologies a public or private company?
Roslin Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Roslin Technologies founded?
Roslin Technologies was founded in 2016. It employs 11 to 50 people.
Where is Roslin Technologies based?
Roslin Technologies is headquartered in Edinburgh, United Kingdom, in the Europe region.
How does Roslin Technologies make money?
Four revenue lines are on record. Cell line product sales (B2B) is the primary driver. The others are scale-up packages and supporting products, custom / tail-ended cell line development and licensing and animal health / veterinary cell line development partnerships.
Who are Roslin Technologies's main competitors?
Direct peers on record are Multus and The Cultured Hub. Emerging players are Aleph Farms, Mosa Meat, Meatable, Upside Foods, BlueNalu and Eat Just (GOOD Meat). Broad incumbents are Cellular Dynamics International (Fujifilm CDI) and Bio-Techne.
Does Roslin Technologies have an API?
No public API is recorded for Roslin Technologies.
What industry is Roslin Technologies in?
Roslin Technologies's product category is Cultivated Meat Cell Lines. Its primary akta.pro industry code is AFANAKAE, Cell Line Development & Banking (Food/AG Cell Lines), with a secondary code of AFANAKAC, Cultivated Meat Producers (Cell-Cultured Meat & Seafood). Its NAICS code is 1129 and its SIC code is 2011.